New Blood Test May Improve Diagnosis and Prognosis of Acute Spinal-Cord Injury
Dato Capt. Mahesan Subramaniam, Co-Founder of United Health Tourism, posted on LinkedIn:
“New blood test may improve diagnosis and prognosis of acute spinal-cord injury.
Researchers have developed a blood test that can detect damage to the spinal cord almost immediately after injury, helping doctors assess severity and predict recovery. The test measures fragments of spinal-cord cell DNA released into the bloodstream, along with key proteins linked to nerve damage. Higher levels of these markers have been shown to correlate with more severe injuries and worse outcomes months later.
In addition to these novel markers, another study found that ordinary blood tests already used in hospitals—tracking things like immune cell counts, electrolytes, and metabolic indicators—can be analyzed over time using machine-learning tools to predict whether a patient has serious spinal-cord damage, will survive, or how well they might recover. These predictions become more accurate as more data accumulate in the first days after injury.
If validated further and adopted widely, these developments might shift spinal-cord injury care from reactive to proactive. By giving clinicians objective data early on, treatment plans and resource allocation can be better tailored to each patient’s risk. Ultimately, patients might benefit from more individualized treatment and improved outcomes based on timely biological insights.”
Find more posts featuring Dato Capt. Mahesan Subramaniam on Hemostasis Today.
-
Sep 5, 2026, 04:16Key Cardiovascular Insights from ESC Congress
-
Sep 5, 2026, 03:30Rob Maloney: Who Are the Real Experts? – The Quiet Resilience of the Bleeding Disorders Community
-
Sep 5, 2026, 03:26Project Elevate Her – Scaling Heights for Bleeding Disorders Awareness – WFH
-
Sep 5, 2026, 03:20Sarah Bassiony: How Do non-Specialists Learn Haematology? – Participate in Our Remote Study
-
Sep 5, 2026, 03:13Omid Seidizadeh: Uncovering the Genetic Architecture of Low Von Willebrand Factor
-
Sep 5, 2026, 03:07Luke McLaughlin: The First Community Article of the Haemophilia Rights Project
-
Sep 5, 2026, 03:00Panagiotis Christoforou: Proud to Contribute to Barts Health’s Leading Role in UK Clinical Trials
-
Sep 5, 2026, 02:51Kassiani Maria Nastouli: Honored to Be Cited in the New ESC Guidelines on the Management of CVD and CKD
-
Sep 5, 2026, 02:44Sedat Gül: Is It Time to Reconsider the 24-Hour Antiplatelet Delay After Thrombolysis?